Dollars for Docs
How Industry Dollars Reach Your Doctors
This database was last updated in October 2019 and should only be used as a historical snapshot. Newer data is available at the Centers for Medicare and Medicaid Services Open Payments site.
MARK D PEGRAM
Listed Specialty: Surgical Oncology
900 BLAKE WILBUR DR, FIRST FLOOR, PALO ALTO, CA, 94304-2201
MARK PEGRAM,
Yearly Payment Breakdown:
2018 Payments At a Glance
86
payments
$98,451
payment total
18
companies paid this doctor
Payment Calendar in 2018
This doctor received a payment on days in 2018.
Each box below represents a single day during the disclosure period. A gray box indicates no payments. The darker the color, the more payments a doctor received that day.
2018
Types of Payments in 2018
Category | Payments | Payment Value |
---|---|---|
Consulting |
16 | $60,387 |
Travel and Lodging |
35 | $18,752 |
Promotional Speaking/Other |
5 | $17,065 |
Food and Beverage |
30 | $2,246 |
Drugs & Devices in 2018
Totals listed below account for all payments from that mention this product. Beginning in 2016, the government began classifying products as drugs, devices, biologics or medical supplies. Below, you will see drugs (drugs and biologics) and devices (devices and medical supplies). If a payment record mentions more than one product, the entire value will be included in each of those products. When no products are listed, they are not included in the list below.
Product Name | Product Type | Payments† |
---|---|---|
Payments with no listed product |
N/A |
$34,383 |
PERJETA |
drug |
$24,341 |
NON-COVERED PRODUCT |
drug |
$18,200 |
KADCYLA |
drug |
$17,326 |
HERCEPTIN |
drug |
$13,981 |
NERLYNX |
drug |
$10,333 |
IBRANCE |
drug |
$5,126 |
RETACRIT |
drug |
$3,200 |
SAR439859 |
drug |
$2,012 |
IMFINZI |
drug |
$537 |
FOUNDATIONACT |
device |
$150 |
FOUNDATIONONE |
device |
$150 |
FOUNDATIONFOCUS |
device |
$150 |
FOUNDATIONONE HEME |
device |
$150 |
FOUNDATIONONE CDX |
device |
$150 |
PIPELINE-ONCOLOGY |
drug |
$74 |
PACLITAXEL |
drug |
$59 |
ZOLADEX |
drug |
$32 |
KISQALI |
drug |
$5 |
† May not add up to dollar total at top of page, since a payment record may not be associated with any product or can be associated with several products. |
Payment Details in 2018
When | How Much | Related To | What For | From | Third Party Payee |
---|---|---|---|---|---|
Mar 9, 2018 | $7,660 | HERCEPTIN NON-COVERED PRODUCT | Consulting | GENENTECH USA, INC. | |
Apr 23, 2018 | $7,561 | PERJETA KADCYLA | Travel and Lodging | F. HOFFMANN-LA ROCHE AG | |
Jul 27, 2018 | $7,500 | No Listed Product | Consulting | PFIZER INTERNATIONAL LLC | |
Mar 16, 2018 | $5,600 | NON-COVERED PRODUCT | Consulting | GENENTECH, INC. | |
Oct 26, 2018 | $5,360 | HERCEPTIN PERJETA KADCYLA | Consulting | GENENTECH USA, INC. | |
Mar 14, 2018 | $4,950 | No Listed Product | Consulting | AMGEN INC. | |
Jul 21, 2018 | $4,800 | NERLYNX | Consulting | PUMA BIOTECHNOLOGY, INC. | |
Apr 20, 2018 | $4,800 | NERLYNX | Consulting | PUMA BIOTECHNOLOGY, INC. | |
Sep 28, 2018 | $4,510 | PERJETA | Consulting | ROCHE PRODUCTS LIMITED | |
May 31, 2018 | $3,835 | No Listed Product | Promotional Speaking/Other | SEATTLE GENETICS, INC. | |
Oct 5, 2018 | $3,540 | No Listed Product | Promotional Speaking/Other | NOVARTIS PHARMACEUTICALS CORPORATION | |
May 3, 2018 | $3,540 | No Listed Product | Promotional Speaking/Other | NOVARTIS PHARMACEUTICALS CORPORATION | |
Feb 22, 2018 | $3,200 | RETACRIT | Promotional Speaking/Other | PFIZER INC. | |
Oct 2, 2018 | $3,125 | IBRANCE | Consulting | PFIZER INC. | |
Apr 23, 2018 | $2,970 | PERJETA KADCYLA | Consulting | F. HOFFMANN-LA ROCHE AG | |
Sep 6, 2018 | $2,950 | No Listed Product | Promotional Speaking/Other | NOVARTIS PHARMACEUTICALS CORPORATION | |
Nov 9, 2018 | $2,500 | NON-COVERED PRODUCT | Consulting | GENENTECH USA, INC. | |
Sep 28, 2018 | $2,205 | PERJETA | Travel and Lodging | ROCHE PRODUCTS LIMITED | |
Dec 5, 2018 | $1,950 | SAR439859 | Consulting | SANOFI-AVENTIS U.S. LLC | |
Jul 3, 2018 | $1,875 | IBRANCE | Consulting | PFIZER INC. | |
Jan 17, 2018 | $1,350 | No Listed Product | Consulting | ASTRAZENECA UK LIMITED | |
Nov 13, 2018 | $900 | No Listed Product | Consulting | ASTRAZENECA UK LIMITED | |
Nov 21, 2018 | $761 | No Listed Product | Travel and Lodging | PFIZER INTERNATIONAL LLC | |
Oct 26, 2018 | $653 | HERCEPTIN PERJETA KADCYLA | Travel and Lodging | GENENTECH USA, INC. | |
May 3, 2018 | $607 | No Listed Product | Travel and Lodging | NOVARTIS PHARMACEUTICALS CORPORATION | |
Oct 5, 2018 | $562 | No Listed Product | Travel and Lodging | NOVARTIS PHARMACEUTICALS CORPORATION | |
May 15, 2018 | $537 | IMFINZI | Consulting | ASTRAZENECA PHARMACEUTICALS LP | |
Mar 16, 2018 | $533 | NON-COVERED PRODUCT | Travel and Lodging | GENENTECH, INC. | |
Jun 23, 2018 | $510 | No Listed Product | Travel and Lodging | PFIZER INTERNATIONAL LLC | |
Jun 23, 2018 | $468 | No Listed Product | Travel and Lodging | PFIZER INTERNATIONAL LLC | |
Nov 9, 2018 | $461 | NON-COVERED PRODUCT | Travel and Lodging | GENENTECH USA, INC. | |
Mar 16, 2018 | $419 | NON-COVERED PRODUCT | Travel and Lodging | GENENTECH, INC. | |
Apr 20, 2018 | $383 | NERLYNX | Travel and Lodging | PUMA BIOTECHNOLOGY, INC. | |
May 31, 2018 | $375 | No Listed Product | Travel and Lodging | SEATTLE GENETICS, INC. | |
Apr 23, 2018 | $328 | PERJETA KADCYLA | Travel and Lodging | F. HOFFMANN-LA ROCHE AG | |
Nov 9, 2018 | $328 | NON-COVERED PRODUCT | Food and Beverage | GENENTECH USA, INC. | |
Sep 6, 2018 | $288 | No Listed Product | Travel and Lodging | NOVARTIS PHARMACEUTICALS CORPORATION | |
May 31, 2018 | $283 | No Listed Product | Travel and Lodging | SEATTLE GENETICS, INC. | |
Jun 28, 2018 | $280 | No Listed Product | Travel and Lodging | AMGEN INC. | |
Sep 28, 2018 | $251 | PERJETA | Travel and Lodging | ROCHE PRODUCTS LIMITED | |
Oct 5, 2018 | $248 | No Listed Product | Travel and Lodging | NOVARTIS PHARMACEUTICALS CORPORATION | |
Oct 5, 2018 | $246 | No Listed Product | Travel and Lodging | NOVARTIS PHARMACEUTICALS CORPORATION | |
Nov 9, 2018 | $234 | NON-COVERED PRODUCT | Travel and Lodging | GENENTECH USA, INC. | |
Oct 26, 2018 | $180 | HERCEPTIN PERJETA KADCYLA | Travel and Lodging | GENENTECH USA, INC. | |
May 16, 2018 | $150 | FOUNDATIONONE FOUNDATIONONE HEME FOUNDATIONONE CDX FOUNDATIONFOCUS FOUNDATIONACT | Food and Beverage | FOUNDATION MEDICINE, INC. | |
Apr 23, 2018 | $146 | PERJETA KADCYLA | Food and Beverage | F. HOFFMANN-LA ROCHE AG | |
Apr 16, 2018 | $144 | No Listed Product | Travel and Lodging | AMGEN INC. | |
Oct 26, 2018 | $128 | HERCEPTIN PERJETA KADCYLA | Food and Beverage | GENENTECH USA, INC. | |
May 3, 2018 | $123 | No Listed Product | Food and Beverage | NOVARTIS PHARMACEUTICALS CORPORATION | |
Jul 21, 2018 | $122 | NERLYNX | Food and Beverage | PUMA BIOTECHNOLOGY, INC. | |
Mar 16, 2018 | $120 | NON-COVERED PRODUCT | Travel and Lodging | GENENTECH, INC. | |
Nov 9, 2018 | $117 | NON-COVERED PRODUCT | Travel and Lodging | GENENTECH USA, INC. | |
Jun 23, 2018 | $115 | No Listed Product | Food and Beverage | PFIZER INTERNATIONAL LLC | |
Sep 6, 2018 | $114 | No Listed Product | Food and Beverage | NOVARTIS PHARMACEUTICALS CORPORATION | |
Oct 5, 2018 | $104 | No Listed Product | Food and Beverage | NOVARTIS PHARMACEUTICALS CORPORATION | |
Sep 6, 2018 | $102 | No Listed Product | Travel and Lodging | NOVARTIS PHARMACEUTICALS CORPORATION | |
Jun 3, 2018 | $101 | IBRANCE | Food and Beverage | PFIZER INC. | |
Nov 9, 2018 | $90 | NON-COVERED PRODUCT | Travel and Lodging | GENENTECH USA, INC. | |
Dec 5, 2018 | $88 | No Listed Product | Food and Beverage | MERCK SHARP & DOHME CORPORATION | |
Dec 4, 2018 | $74 | PIPELINE-ONCOLOGY | Food and Beverage | GENZYME CORPORATION | |
Mar 16, 2018 | $73 | NON-COVERED PRODUCT | Travel and Lodging | GENENTECH, INC. | |
Apr 20, 2018 | $71 | NERLYNX | Travel and Lodging | PUMA BIOTECHNOLOGY, INC. | |
Jun 5, 2018 | $70 | No Listed Product | Food and Beverage | MERCK SHARP & DOHME CORPORATION | |
Mar 16, 2018 | $65 | NON-COVERED PRODUCT | Food and Beverage | GENENTECH, INC. | |
Feb 5, 2018 | $60 | No Listed Product | Travel and Lodging | AMGEN INC. | |
Dec 3, 2018 | $59 | PACLITAXEL | Food and Beverage | ATHENEX PHARMACEUTICAL DIVISION, LLC | |
May 31, 2018 | $56 | No Listed Product | Food and Beverage | SEATTLE GENETICS, INC. | |
May 31, 2018 | $51 | No Listed Product | Food and Beverage | SEATTLE GENETICS, INC. | |
Apr 16, 2018 | $46 | No Listed Product | Food and Beverage | AMGEN INC. | |
Apr 20, 2018 | $43 | NERLYNX | Travel and Lodging | PUMA BIOTECHNOLOGY, INC. | |
Dec 5, 2018 | $43 | SAR439859 | Travel and Lodging | SANOFI-AVENTIS U.S. LLC | |
Apr 20, 2018 | $40 | NERLYNX | Food and Beverage | PUMA BIOTECHNOLOGY, INC. | |
May 31, 2018 | $34 | No Listed Product | Food and Beverage | SEATTLE GENETICS, INC. | |
Jun 5, 2018 | $32 | ZOLADEX | Food and Beverage | TERSERA THERAPEUTICS LLC | |
Apr 20, 2018 | $31 | NERLYNX | Food and Beverage | PUMA BIOTECHNOLOGY, INC. | |
Dec 6, 2018 | $30 | PERJETA | Food and Beverage | GENENTECH USA, INC. | |
May 31, 2018 | $30 | No Listed Product | Food and Beverage | SEATTLE GENETICS, INC. | |
Oct 5, 2018 | $29 | No Listed Product | Food and Beverage | NOVARTIS PHARMACEUTICALS CORPORATION | |
Apr 20, 2018 | $28 | NERLYNX | Food and Beverage | PUMA BIOTECHNOLOGY, INC. | |
Aug 14, 2018 | $25 | IBRANCE | Travel and Lodging | PFIZER INC. | |
Dec 5, 2018 | $19 | SAR439859 | Travel and Lodging | SANOFI-AVENTIS U.S. LLC | |
Dec 3, 2018 | $18 | PERJETA | Food and Beverage | GENENTECH USA, INC. | |
Apr 17, 2018 | $16 | No Listed Product | Food and Beverage | AMGEN INC. | |
Jul 21, 2018 | $14 | NERLYNX | Food and Beverage | PUMA BIOTECHNOLOGY, INC. | |
May 31, 2018 | $10 | No Listed Product | Travel and Lodging | SEATTLE GENETICS, INC. | |
Feb 12, 2018 | $5 | KISQALI | Food and Beverage | NOVARTIS PHARMACEUTICALS CORPORATION |
See this doctor’s Open Payments page →
Note: We have made some effort to normalize the data and eliminate duplicates, but the data is primarily as it has been reported by the companies to the Centers for Medicare and Medicaid Services. To purchase the normalized data, please visit the ProPublica Data Store. If you spot an error, please let us know at [email protected].
This site includes data published by the Centers for Medicare and Medicaid Services on June 28, 2019.